Simplicity is a virtue.

From Washington, DC,

• Congress remains on the campaign trail this week.

• Per an October 23, 2024 Department of Health and Human Services news release,
  • “The Trump Administration today announced the America First Seafood Strategy, Restoring American Seafood Competitiveness [PDF], a coordinated federal plan to strengthen American seafood production, modernize infrastructure, expand markets for U.S. fishermen and processors, and combat unfair foreign competition. The strategy advances President Trump’s Executive Order, Restoring American Seafood Competitiveness, and his commitment to rebuild America’s seafood industry, strengthen domestic production, and Make America Healthy Again by expanding access to nutritious, American-caught seafood as part of a healthy diet.” * * *
  • “The draft [FDA] guidance notes that U.S. origin statements should be fully substantiated. Ensuring the integrity of these statements helps protect both consumers and the producers who invest in American sourcing. For more information, visit Seafood.gov.

• FedSmith reports,
  • “The Social Security Administration (SSA) announced on October 20 that it is including a new insert with Social Security cards mailed to newborns through its Enumeration at Birth program. The insert explains how parents can claim and manage a Trump Account, including how eligible children can receive a one-time $1,000 contribution from the Treasury Department.”
  • “The full announcement is available in SSA’s official release.”

From the U.S. Office of Personnel Management front,

• FedSmith explains “How Starting an HSA This Open Season Can Cut Costs, Lower Taxes, and Build Savings.”

• Yahoo Finance adds,
  • “A 62-year-old taking an overnight mail-processing job is choosing a paycheck, but the job works mostly as a health insurance plan. As of January 1, 2025, postal workers left the Federal Employees Health Benefits program for the Postal Service Health Benefits (PSHB) program. A non-career hire can join PSHB after an initial term, and the Postal Service pays most of the premium; after five years of career service and continuous enrollment, that subsidized plan becomes retiree coverage for life.
  • “A 62-year-old taking an overnight mail-processing job is choosing a paycheck, but the job works mostly as a health insurance plan. As of January 1, 2025, postal workers left the Federal Employees Health Benefits program for the Postal Service Health Benefits (PSHB) program. A non-career hire can join PSHB after an initial term, and the Postal Service pays most of the premium; after five years of career service and continuous enrollment, that subsidized plan becomes retiree coverage for life.”

From the public health and medical / Rx research front,

• STAT News reports,
  • “No surprise, the arena-sized room was packed with ESMO attendees eager to see Georgina Long of the Melanoma Institute Australia present the intismeran INTerpath-001 study results. The unfortunate data leak on Thursday made her talk less dramatic, but at the end, she received extended applause and a limited standing ovation. 
  • Long summarized the intismeran results — a 42% reduction in the risk of disease recurrence and a 38% reduction in the risk of distant metastasis-free survival — as a “new benchmark for adjuvant treatment of melanoma.”
  • “More critically,” she added, “it establishes intismeran as a landmark advance in personalized cancer medicine.” 
  • “The full trial data will be published next month in the New England Journal of Medicine, Long also noted. 
  • “Inge Marie Svane of the University of Copenhagen, the discussant following the data presentation, was positive if not overly enthusiastic about the trial, describing the results as “compelling” and adding that they “mark a crucial moment for personalized cancer vaccines.”
  • “But Svane also pointed to a number of outstanding questions, including whether there would be a survival benefit with intismeran, and what exactly was driving the vaccine’s benefit — was it the specific targeting of the neoantigens, or was it the general immune boost that studies have suggested mRNA vaccines provide?
  • “She also took no position on the best way to treat the approximately 40% of higher risk melanoma patients enrolled in the study — a key debate with commercial implications. If intismeran is approved, it will compete against neoadjuvant immunotherapy, or treating patients before surgery. Svane laid out pros and cons of each approach, leaving the question of which will benefit patients more unanswered.”

• Healio relates,
  • “A phase 3 clinical trial revealed that the investigational vaccine candidate — known as LB6V — showed more than 70% efficacy against confirmed Lyme disease, according to results presented at IDWeek.
  • “But, in the end, the drug failed to hit its primary endpoint.
  • “LB6V has a “clinically meaningful” efficacy, researcher Paul G. Auwaerter, MD, clinical director of the division of infectious diseases and professor of medicine at Johns Hopkins University School of Medicine, said during the presentation.” * * *
  • “I believe that LB6V is safe and has a favorable side-effect profile,” Auwaerter said.” * * *
  • “Auwaerter did not mention the drug’s potential approval or launch during his presentation.”
    
• Genetic Engineering and Biotechnology News adds,
  • “The results of a preclinical study headed by researchers at Johns Hopkins University School of Medicine suggest that the Bacillus Calmette-Guerin (BCG) vaccine, which is widely used to prevent tuberculosis and treat bladder cancer, may also have properties that reduce the risk for dementia. BCG is a live, weakened vaccine made from an altered strain of the bacterium Mycobacterium bovis.
  • “The team found that in mice genetically engineered to develop biological symptoms of dementia (PS19 mice), those animals that received the BCG vaccine were less likely to show hallmark signs of the disease, such as neurofibrillary (tau) tangles (NFTs) in the brain, sustained immune cell activation, and memory loss compared to mice that received no vaccine. BCG-treated mice performed better in a novel object recognition test, and showed improved maintenance of body-weight and survival.
  • “Research lead William Bishai, MD, PhD, co-director of the Johns Hopkins Center for Tuberculosis Research, believes that myeloid cells in the central nervous system and brain are using information from BCG to recognize and help the body respond to the formation of plaques and tangles characteristic of Alzheimer’s disease and related dementias. Bishai said, “We’re hard at work trying to understand the detailed mechanism for how it works, but this research points to early clues that aspects of trained immunity are likely driving this response.”
    
• Health Day lets us know,
  • “Jumping rope, stair climbing, power yoga, vigorous cleaning and gardening can all count as at-home cardio
  • “Adults should aim for 150 to 300 minutes of moderate or 75 to 150 minutes of vigorous activity weekly
  • “Short bursts of movement add up, so even climbing a few flights of stairs counts toward your weekly goal.”

From the U.S. healthcare business and artificial intelligence front,

• pwc consulting informs us,
  • “American healthcare was built by local institutions and independent physicians, yet it is now evaluated on national cost trends, consistent quality, and compliance with standardized payment models, all while still being expected to deliver care locally and personally. That tension, not any single policy or technology, is the throughline behind every challenge in this paper.
  • “The system faces seven distinct but connected challenges, spanning consumer expectations, care coordination, innovation speed, regional divergence, chronic care, national infrastructure, and technology adoption.
  • “Each of these seven structural challenges have a clear historical parallel, from 19th-century public health reform to the rise of AI, showing these are patterns, not new problems.
  • “The real bottleneck isn’t invention, it’s adoption that challenges the conventional norms and barriers that keep proven solutions from reaching scale. Time and again, technology and care models have proven themselves years or decades before the system used them.
  • “The next era won’t be measured by activity, it’ll be measured by impact. The organizations that win will likely be judged by how much healthier people became, not how many visits, procedures, or dollars were logged along the way.”

• Beckers Hospital Review reports,
  • “Duluth, Minn.-based Essentia Health reported a 1.2% operating margin in fiscal 2026, down from 2.2% a year earlier, as expenses outpaced revenue growth ahead of its proposed merger with Bloomington, Minn.-based HealthPartners.
  • “Essentia reported $42.3 million in operating income for the fiscal year ended June 30, down 41% from $71.6 million in fiscal 2025, according to its Oct. 14 audited financial report. 
  • “Operating revenue increased 6.4% year over year to $3.49 billion, while operating expenses rose 7.5% to $3.45 billion. Patient service revenue grew 7.1% to $3.41 billion, driven primarily by outpatient revenue, which increased from $2.48 billion to $2.67 billion. Inpatient revenue rose from $673 million to $702 million. Salaries, wages and benefits increased 6.3% to $2.02 billion, while supply expenses climbed 11.4% to $809.5 million.
  • “Essentia reported $281.8 million in nonoperating gains, up from $169 million in fiscal 2025, driven largely by investment gains. The system posted a $324 million in net income, compared with $241 million a year earlier.”
• and
  • “Greensboro, N.C.-based Cone Health plans to acquire three pharmacy businesses in Reidsville, N.C., expanding its retail pharmacy footprint and adding long-term care pharmacy services.
  • “The agreement includes Carolina Apothecary, Belmont Pharmacy and Rx Care, which have served Rockingham County residents for decades. The deal is expected to close in early 2027, pending regulatory approvals and closing conditions.
  • “The businesses will become Cone Health Community Pharmacy locations, offering closer coordination between pharmacists and healthcare providers, competitive medication pricing and onsite vaccinations.’

• Beckers Payer Issues adds,
  • “AI, new product lines, shrinking broker networks and increasingly self-directed consumers will reshape the health insurance landscape in 2027, according to two reports from Forrester published Oct. 14, which covered the global insurance and healthcare industries broadly.
  • “Here are the firm’s 10 health insurance industry predictions for next year:
    • “Half of the 10 largest payers will launch alternative health plans.
      • “Existing alternative health plan examples include UnitedHealthcare’s Surest and Health Care Service Corporation’s new Easify Edge product’.
    • “More than half of consumers will start their healthcare journey using public AI models (such as ChatGPT or Claude), with 42% of consumers polled by Forrester already using an answer engine for healthcare advice.” 
    • “A third of insurers will integrate agentic AI into customer experience, but most will not let it make binding coverage or claims decisions. Forrester pointed to Allianz’s Project Nemo as an example of how large payers are using agentic AI to automate analysis and orchestrate workflows.”
    • “AI agents, not physicians, will perform 20% of routine care check-ins.”
    • “GLP-1 adoption will reach 20% of Americans, inspiring new drug pathways.”
    • “At-home tests will become a new digital divide and increase healthcare inequities.”

• Beckers Physicians Leadership tells us,
  • “Median pay for cardiologists 35 and younger fell about 19% in 2025, even as overall cardiology compensation reached a record high, according to an October MedAxiom’s 2026 Cardiovascular Provider Compensation and Production Survey.
  • “Early-career cardiologists earned a median $476,850 in 2025, down from $586,769 in 2024. It was the second straight annual decline for the group. Over the same period, overall median compensation per full-time cardiologist rose nearly 5%, to $727,712 from $694,954, and every cardiology subspecialty posted its highest median pay in the survey’s history. 
  • “MedAxiom described the decline as surprising, given how hard cardiology programs are working to recruit physicians. The report doesn’t collect starting salary data, so it uses physicians 35 and younger as a proxy for early-career pay.”